MARTINA, Valentino
MARTINA, Valentino
SCIENZE MEDICHE
Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1.
2001-01-01 MARTINA V; BRUNO GA; ZUMPANO E; ORIGLIA C; QUARANTA L; GP. PESCARMONA
Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus.
1995-01-01 MARTINA V ;BRUNO G ;TAGLIABUE M ;BERTAINA S ;MACCARIO M ;GROTTOLI S ;PROCOPIO M ;OZZELLO A ;CAMANNI F
Bone metabolism in type 2 diabetes mellitus
1999-01-01 G.C. ISAIA; P. ARDISSONE; M. DI STEFANO; D. FERRARI; V. MARTINA; M. PORTA; M. TAGLIABUE; G.M. MOLINATTI
Chronic treatment with pirenzepine decreases growth hormone secretion in insulin-dependent diabetes mellitus.
1989-01-01 MARTINA V ;MACCARIO M ;TAGLIABUE M ;CORNO M ;CAMANNI F
Clinical and genetic variability in XX sex-reversed patients.
1996-01-01 MANIERI C; TAGLIABUE M; R. NOVI; DI BISCEGLIE C; ARDUINO C; FORNENGO R; BRANCALEONI V; MARTINA V
Comparison of Monotard and Ultratard insulin at bedtime in a model of optimized insulin therapy in Italy.
1989-01-01 MARTINA V ;TAGLIABUE M ;MACCARIO M ;D'ANTONA G ;CAMANNI F
Dehydroepiandrosterone positively affects nitric oxide production in platelets of normal subjects.
2006-01-01 A. Benso; C. Origlia; G. Bruno; A. Capizzi; R. Gambino; M. Cassader; R. Granata; G.P. Pescarmona; E. Ghigo; V. Martina.
Deydroepiandrosterone positevely affects nitric oxide production in the platelets of normal subjects.
2003-01-01 V.Martina; C.Origlia; G.A.Bruno; A.Capizzi; M.Bo; G.Mercadante; R.Gambino; M.Cassader; G.P.Pescarmona
DHEAS and platelet cGMP variations during lifespan.
2001-01-01 C.Origlia; F.Tassone; G.A.Bruno; R.Gambino; M.Cassader; M.Ferri; G.P.Pescarmona; V.Martina
FEMALE PATIENTS WITH DOWN SYNDROME (DS) SHOW A GREATER INSULIN RESISTANCE IN COMPARISON WITH NORMAL FEMALES (NF)
2003-01-01 C. Origlia; G.Aimaretti; R. Giordano; M. Pellegrino; S. Rovere; E. Ghigo; V. Martina
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences
2004-01-01 Benso A.; Broglio F.; Marafetti L.; Lucatello B.; Seardo M.A.; Granata R.; Martina V.; Papotti M.; Muccioli G.; Ghigo E.
Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans
2004-01-01 BROGLIO F; GOTTERO C; PRODAM F; DESTEFANIS S; GAUNA C; ME E; RIGANTI F; VIVENZA D; RAPA A; MARTINA V; ARVAT E; BONA G; VAN DER LELY AJ; GHIGO E
GHRELIN SECRETION IS INHIBITED BY GLUCOSE LOAD AND INSULIN-INDUCED HYPOGLYCEMIA BUT UNAFFECTED BY GLUCAGON AND ARGININE IN HUMANS
2004-01-01 E. Me; F. Broglio; C. Gottero; F. Prodam; S. Destefanis; A. Benso; R. Giordano; L. Filtri; F. Riganti; V. Martina; E. Arvat; E. Ghigo
I livelli plasmatici di dHEAS influenzano la produzione di cGMP piastrinico nel soggetto normale e nel soggetto affetto da DM T2.
2001-01-01 C.Origlia; F.Tassone; G.A.Bruno; R.Gambino; M.Cassader; M.Ferri; G.P.Pescarmona; V.Martina
In normal subjects HOMA positively correlates with serum ferritin, a cardiovascular risk factor.
2003-01-01 C.A. Origlia; R. Gambino; M. Cassader; G. Bruno; V. Martina.
Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus.
1992-01-01 MARTINA V ;MIOLA C ;MACCARIO M ;TALLIANO M ;ARVAT E ;GHIGO E ;CAMANNI F
Interaction of free fatty acids and arginine on growth hormone secretion in man.
1994-01-01 MACCARIO M ;PROCOPIO M ;LOCHE S ;CAPPA M ;MARTINA V ;CAMANNI F ;GHIGO E
L-Arginine
2005-01-01 MACCARIO M; ARVAT E; AIMARETTI G; MARTINA V; GIORDANO R; LANFRANCO F; MARAFETTI L; SEARDO M; BALDI M; GHIGO E
La ferritinemia: possibile marker di insulino resistenza.
2002-01-01 C.Origlia; G.P.Pescarmona; G.A.Bruno; A.Gariboldi; R.Gambino; M.Cassader; V.Martina.
La produzione di ossido nitrico si riduce con l’età e correla con il DHEAS e l’IGF-I nel soggetto normale.
2002-01-01 V.Martina; C.Origlia; G.A.Bruno; M.Ferri; R.Gambino; M.Cassader; G.P.Pescarmona
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1. | 2001 | MARTINA V; BRUNO GA; ZUMPANO E; ORIGLIA C; QUARANTA L; GP. PESCARMONA | |
Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus. | 1995 | MARTINA V ;BRUNO G ;TAGLIABUE M ;BERTAINA S ;MACCARIO M ;GROTTOLI S ;PROCOPIO M ;OZZELLO A ;CAMANNI F | |
Bone metabolism in type 2 diabetes mellitus | 1999 | G.C. ISAIA; P. ARDISSONE; M. DI STEFANO; D. FERRARI; V. MARTINA; M. PORTA; M. TAGLIABUE; G.M. MOLINATTI | |
Chronic treatment with pirenzepine decreases growth hormone secretion in insulin-dependent diabetes mellitus. | 1989 | MARTINA V ;MACCARIO M ;TAGLIABUE M ;CORNO M ;CAMANNI F | |
Clinical and genetic variability in XX sex-reversed patients. | 1996 | MANIERI C; TAGLIABUE M; R. NOVI; DI BISCEGLIE C; ARDUINO C; FORNENGO R; BRANCALEONI V; MARTINA V | |
Comparison of Monotard and Ultratard insulin at bedtime in a model of optimized insulin therapy in Italy. | 1989 | MARTINA V ;TAGLIABUE M ;MACCARIO M ;D'ANTONA G ;CAMANNI F | |
Dehydroepiandrosterone positively affects nitric oxide production in platelets of normal subjects. | 2006 | A. Benso; C. Origlia; G. Bruno; A. Capizzi; R. Gambino; M. Cassader; R. Granata; G.P. Pescarmona; E. Ghigo; V. Martina. | |
Deydroepiandrosterone positevely affects nitric oxide production in the platelets of normal subjects. | 2003 | V.Martina; C.Origlia; G.A.Bruno; A.Capizzi; M.Bo; G.Mercadante; R.Gambino; M.Cassader; G.P.Pescarmona | |
DHEAS and platelet cGMP variations during lifespan. | 2001 | C.Origlia; F.Tassone; G.A.Bruno; R.Gambino; M.Cassader; M.Ferri; G.P.Pescarmona; V.Martina | |
FEMALE PATIENTS WITH DOWN SYNDROME (DS) SHOW A GREATER INSULIN RESISTANCE IN COMPARISON WITH NORMAL FEMALES (NF) | 2003 | C. Origlia; G.Aimaretti; R. Giordano; M. Pellegrino; S. Rovere; E. Ghigo; V. Martina | |
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences | 2004 | Benso A.; Broglio F.; Marafetti L.; Lucatello B.; Seardo M.A.; Granata R.; Martina V.; Papotti M.; Muccioli G.; Ghigo E. | |
Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans | 2004 | BROGLIO F; GOTTERO C; PRODAM F; DESTEFANIS S; GAUNA C; ME E; RIGANTI F; VIVENZA D; RAPA A; MARTINA V; ARVAT E; BONA G; VAN DER LELY AJ; GHIGO E | |
GHRELIN SECRETION IS INHIBITED BY GLUCOSE LOAD AND INSULIN-INDUCED HYPOGLYCEMIA BUT UNAFFECTED BY GLUCAGON AND ARGININE IN HUMANS | 2004 | E. Me; F. Broglio; C. Gottero; F. Prodam; S. Destefanis; A. Benso; R. Giordano; L. Filtri; F. Riganti; V. Martina; E. Arvat; E. Ghigo | |
I livelli plasmatici di dHEAS influenzano la produzione di cGMP piastrinico nel soggetto normale e nel soggetto affetto da DM T2. | 2001 | C.Origlia; F.Tassone; G.A.Bruno; R.Gambino; M.Cassader; M.Ferri; G.P.Pescarmona; V.Martina | |
In normal subjects HOMA positively correlates with serum ferritin, a cardiovascular risk factor. | 2003 | C.A. Origlia; R. Gambino; M. Cassader; G. Bruno; V. Martina. | |
Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus. | 1992 | MARTINA V ;MIOLA C ;MACCARIO M ;TALLIANO M ;ARVAT E ;GHIGO E ;CAMANNI F | |
Interaction of free fatty acids and arginine on growth hormone secretion in man. | 1994 | MACCARIO M ;PROCOPIO M ;LOCHE S ;CAPPA M ;MARTINA V ;CAMANNI F ;GHIGO E | |
L-Arginine | 2005 | MACCARIO M; ARVAT E; AIMARETTI G; MARTINA V; GIORDANO R; LANFRANCO F; MARAFETTI L; SEARDO M; BALDI M; GHIGO E | |
La ferritinemia: possibile marker di insulino resistenza. | 2002 | C.Origlia; G.P.Pescarmona; G.A.Bruno; A.Gariboldi; R.Gambino; M.Cassader; V.Martina. | |
La produzione di ossido nitrico si riduce con l’età e correla con il DHEAS e l’IGF-I nel soggetto normale. | 2002 | V.Martina; C.Origlia; G.A.Bruno; M.Ferri; R.Gambino; M.Cassader; G.P.Pescarmona |